Business / Finance

RSS

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialization Fund managed by Brandon Capital.

9 Jan 2020

Airway Therapeutics receives funding to advance BPD treatment

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the injury cycle of inflammation for patients with respiratory and inflammatory diseases, announced today the closing of a $15.5 million oversubscribed Series C financing round.

8 Jan 2020

Hitachi’s diagnostic imaging business will strengthen Fujifilm’s product line, says GlobalData

Following the news that Japan’s Fujifilm Holdings Corp has agreed to acquire Hitachi Ltd.’s diagnostic imaging business for approximately JPY179bn (US$1.64bn); Rohit Anand, Practice Head of Medical Devices at GlobalData, a leading data and analytics company, offers his view.

2 Jan 2020

Stilla Technologies announces key leadership hires

Stilla Technologies, the provider of pioneering digital PCR solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director.

11 Dec 2019

PREDiCT: Tumor Models San Francisco Summit 2020

The community of preclinical immuno-oncology scientific Pharma and Biotechs meet again to advance their preclinical insights through robust models utilization to accelerate IO development & clinical confidence.

25 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

Olympus reveals corporate strategy in central Tokyo

Olympus Corporation today announced its Corporate Strategy in central Tokyo. The announcement follows the company's earlier announcement in January this year, when significant changes in governance, the headquarters move of the Therapeutic Solutions business to the US, as well as a cost containment program were announced as a starting point of the company's extensive transformation efforts.

From Evident - Medical and Surgical 8 Nov 2019

Fear of missing out?

In this webinar, you will review best practices, short cuts, and tricks-of-the-trade to become more successful in developing effective HPLC methods (potency and ICH-compliant stability-indicating assays) using method templates and universal generic gradient methods.

From Pittcon 6 Nov 2019

CryoCapCell appoint Labtech as UK distributor

Labtech International has been appointed as the UK and Ireland distributor of CryoCapCell, the France-based manufacturer of the technology-leading HPM Live μ high pressure freezing system.

From Labtech International Ltd 6 Nov 2019

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the rights to receive royalties on the sales outside of Japan for an investigational anti-cancer agent tazemetostat (generic name) to Royalty Pharma.

5 Nov 2019

Bosch and Nanalysis announce joint product development collaboration

Nanalysis Scientific Corp., is pleased to announce that as of October 23rd , it has entered into a collaboration agreement with Robert Bosch GmbH to jointly develop products for the growing market industrial Nuclear Magnetic Resonance products for applications such as on-board fuel analyzers for cargo ships, driven by new international environmental standards against dirty fuels, which would be distributed by Bosch.

From Nanalysis Corp. 1 Nov 2019

Finnish biotech innovation hits billion-euro markets

Grundium, a technology company in the digital pathology sphere, has entered into a major dealership contract with Alliance Global Group.

From Grundium 24 Oct 2019

New $30M contract signed to accelerate TB vaccine development across the country

Tuberculosis (TB) is the number-one cause of death from an infectious disease in the world: In 2017, the most recent data available, 10 million people developed TB and 1.6 million died.

23 Oct 2019

Quanterix to release third quarter 2019 financial results and host conference call on November 6, 2019

Quanterix announced that it will release its financial results for third quarter 2019 after the close of trading on Wednesday, November 6, 2019.

From Quanterix 22 Oct 2019

BioStreamline project outcomes

CPI have reported successful outcomes the £11.

From Sphere Bio 16 Oct 2019

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics, announce it has opened a new office space at Granta Park. New facilities support the Company’s accelerated expansion.

From Sphere Bio 16 Oct 2019

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

Sphere Fluidics, announced that it has closed an additional tranche of investment of $2.9 million, securing a total of $4.8 million in investment.

From Sphere Bio 16 Oct 2019

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics, announced today that it has appointed six new employees and plans to hire four more staff in its UK and US sites.

From Sphere Bio 16 Oct 2019

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics, announced that is has closed a $2 million (circa £1.5 million) investment round.

From Sphere Bio 16 Oct 2019

Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand

Pulsify Medical, a digital medical technology company focused on the development of wearable ultrasound patches, announced the first closing of its seed funding round, raising € 2.6 million euro.

From Imec 15 Oct 2019

Business / Finance

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Airway Therapeutics receives funding to advance BPD treatment

Hitachi’s diagnostic imaging business will strengthen Fujifilm’s product line, says GlobalData

Stilla Technologies announces key leadership hires

PREDiCT: Tumor Models San Francisco Summit 2020

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

Olympus reveals corporate strategy in central Tokyo

Fear of missing out?

CryoCapCell appoint Labtech as UK distributor

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Bosch and Nanalysis announce joint product development collaboration

Finnish biotech innovation hits billion-euro markets

New $30M contract signed to accelerate TB vaccine development across the country

Quanterix to release third quarter 2019 financial results and host conference call on November 6, 2019

BioStreamline project outcomes

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics closes a $4.8 million USD (£3.7 million) funding round

Sphere Fluidics hires 10 new UK and US staff in its plan to scale internationally

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News